Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Collaboration agreement
0
0
0
0
27
5
15
Contract and other
0
0
1
2
2
0
4
Total revenue
0
0
1
2
30
5
19
Cost of goods sold
0
0
0
0
0
0
2
Research and development
16
8
14
25
26
25
22
General and administrative
4
4
7
7
10
18
14
Restructuring costs
0
0
0
0
0
0
1
Total operating costs and expenses
19
12
20
32
36
43
39
Loss from operations
-19
-12
-19
-30
-7
-38
-20
Interest expense
-1
-1
-2
-2
-2
-3
-3
Interest income and other income (expense), net
0
0
0
0
-15
7
2
Non-cash interest expense on liability related to sale of future royalties
0
0
0
0
0
0
-2
Total other (expense) income
0
-1
2
-1
-17
4
-4
Net loss before income taxes
0
0
0
0
-23
-33
-24
Provision for income taxes
0
0
0
0
0
0
-1
Net loss
-20
-14
-20
-33
-23
-33
-24
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 7, 2016 n/a
calculated values,
restated on Mar 7, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (37 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
3
8
48
88
60
108
Short-term investments
n/a
1
28
12
15
15
6
Accounts receivable, net
n/a
0
0
0
0
0
3
Inventories
n/a
0
0
0
0
0
0
Prepaid expenses and other current assets
n/a
2
2
2
1
1
2
Total current assets
n/a
6
38
62
105
76
119
Property and equipment, net
n/a
1
2
2
5
10
9
Restricted cash
n/a
0
0
0
0
0
0
Other assets
n/a
0
0
0
0
0
0
Total assets
n/a
7
41
65
110
86
128
Liabilities and owners' equity
Accounts payable
n/a
1 543000
2 1530000
2 2235000
2 2341000
2 2431000
2 1561000
Accrued liabilities
n/a
1 859000
3 2511000
5 4653000
4 3904000
4 3654000
4 3956000
Convertible notes
n/a
7 6805000
0 0
0 0
0 0
0 0
0 0
Long-term debt, current portion
n/a
5 5204000
4 3804000
7 7443000
0 0
7 6859000
5 4541000
Deferred revenue, current portion
n/a
0 0
0 0
0 0
1 623000
1 787000
3 2604000
Liability related to the sale of future royalties, current portion
n/a
0 0
0 0
0 0
0 0
0 0
0 118000
Total current liabilities
n/a
13 13411000
8 7845000
14 14331000
7 6868000
14 13731000
13 12780000
Deferred rent, net of current portion
n/a
0 245000
0 15000
0 312000
0 188000
1 529000
0 245000
Long-term debt, net of current portion
n/a
0 0
15 15275000
9 8530000
14 14364000
18 18015000
16 16381000
Call option liability
n/a
1 596000
0 0
0 0
0 0
0 0
0 0
Convertible Preferred Stock Warrant Liability
n/a
3 2529000
0 0
0 0
0 0
0 0
0 0
Deferred revenue, net of current portion
n/a
0 0
0 0
0 0
2 2007000
2 1626000
1 593000
Liability related to the sale of future royalties, net of current portion
n/a
0 0
0 0
0 0
0 0
0 0
63 63494000
Contingent put option liability
n/a
0 0
0 232000
0 82000
0 334000
0 282000
0 266000
Warrant liability
n/a
0 0
0 0
7 7418000
13 13111000
6 5577000
1 913000
Total liabilities
n/a
17 16781000
23 23367000
31 30673000
37 36872000
40 39760000
95 94672000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Convertible preferred stock, $0.001 par value-10,000,000 shares and 46,736,125 shares authorized as of December 31, 2011 and 2010; no shares and 7,151,802 shares issued and outstan
n/a
56 55941000
0 0
0 0
0 0
0 0
0 0
Common stock, $0.001 par value—100,000,000 shares authorized as of December 31, 2015 and December 31, 2014; 45,273,772 and 43,712,363 shares issued and outstanding as of December 3
n/a
0 3000
0 22000
0 37000
0 43000
0 43000
0 45000
Additional paid-in capital
n/a
3 2668000
106 106110000
156 155836000
219 218568000
225 225423000
236 236274000
Accumulated deficit
n/a
-69 -68563000
-89 -88664000
-122 -122027000
-145 -145453000
-179 -178806000
-203 -203205000
Accumulated other comprehensive loss
n/a
0 0
0 0
0 1000
0 1000
0 -4000
0 -1000
Total stockholders’ equity
n/a
-66 -65892000
17 17468000
34 33847000
73 73159000
47 46656000
33 33113000
Total liabilities and stockholders’ equity
n/a
7 6830000
41 40835000
65 64520000
110 110031000
86 86416000
128 127785000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Mar 7, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (39 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net loss
-20
-14
-20
-33
-23
-33
-24
Non-cash interest expense on liability related to sale of future royalties
0
0
0
0
0
0
2
Depreciation and amortization
0
0
1
1
1
1
2
Amortization of premium/discount on investments, net
0
0
0
0
0
0
0
Interest expense related to debt financing
0
1
2
1
0
1
1
Stock-based compensation
0
1
2
2
3
4
5
Realized gain on sale of investments
0
0
0
0
0
0
0
Revaluation of put option and PIPE warrant liabilities
0
1
-2
1
14
-7
-2
Loss on extinguishment of debt
0
0
0
0
1
0
0
Other
0
0
0
0
0
0
0
Loss on disposal and impairment of property and equipment
0
0
0
0
0
0
1
Accounts receivable
0
0
0
0
0
0
-3
Inventories
0
0
0
0
0
0
0
Prepaid expenses and other assets
0
0
0
0
1
0
-1
Restricted cash
0
0
0
0
0
0
0
Accounts payable
0
0
1
1
0
0
-1
Accrued liabilities
0
-1
2
2
-1
0
0
Deferred revenue
0
0
0
0
3
0
1
Deferred rent
0
0
0
0
0
0
0
Net cash used in operating activities
-19
-12
-15
-25
0
-34
-20
Purchase of property and equipment
0
0
-2
-1
-3
-6
-1
Purchase of investments
-14
-5
-39
-27
-28
-17
-7
Proceeds from sales of investments
20
0
2
0
0
0
0
Proceeds from maturities of investments
3
10
10
43
24
17
17
Net cash provided by (used in) investing activities
9
5
-30
15
-7
-6
8
Net proceeds from sale of future royalties
0
0
0
0
0
0
61
Proceeds from issuance of common stock in equity offerings, net of offering costs
0
0
35
53
48
0
0
Proceeds from the issuance of long-term debt
0
0
20
0
15
10
0
Payment of long-term debt
-3
-5
-5
-4
-16
0
-5
Proceeds from issuance of convertible promissory notes
0
8
0
0
0
0
0
Net proceeds from issuance of common stock through equity plans
0
0
0
0
0
0
0
Proceeds from issuance of convertible preferred stock, net of issuance costs
15
0
0
0
0
0
0
Payment of debt modification transaction costs
0
0
0
0
0
0
0
Net proceeds from issuance of common stock through equity plans and exercise of warrants
0
0
0
0
2
2
3
Net cash provided by financing activities
12
3
50
50
48
12
60
Net increase (decrease) in cash and cash equivalents
1
-4
5
40
40
-28
48
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo